GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.

Guangzhou Kingmed Diagnostics Group Co., Ltd.

Equities

603882

CNE100002VW1

Healthcare Facilities & Services

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
42.55 ^CNY	-3.95%		-7.66%	-32.00%

Apr. 10	Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024.	CI
Apr. 09	Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on January 20, 2024, has closed with 1,781,400 shares, representing 0.38% for CNY 99.99 million.	CI

Guangzhou Kingmed Diagnostics Group Co., Ltd. Announces Cash Dividend for the Year 2019, Payable on July 1, 2020

June 21, 2020

Guangzhou Kingmed Diagnostics Group Co., Ltd. announced cash dividend of RMB 0.136 (taxes included) per A share for the year 2019. Record date is on June 30, 2020, ex-dividend date is on July 1, 2020 and cash dividend payable date is on July 1, 2020.

Latest news about Guangzhou Kingmed Diagnostics Group Co., Ltd.

Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024.	Apr. 09	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on January 20, 2024, has closed with 1,781,400 shares, representing 0.38% for CNY 99.99 million.	Apr. 08	CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024.	Apr. 01	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	Jan. 19	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan.	Jan. 18	CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023.	Jan. 11	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on December 19, 2023, has closed with 1,696,800 shares, representing 0.36% for CNY 99.99 million.	Jan. 10	CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023.	Jan. 02	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	Dec. 18	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan.	Dec. 17	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.(SHSE:603882) dropped from SSE 180 Index	Dec. 08	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.(SHSE:603882) dropped from Shanghai Stock Exchange 180 Value Index	Dec. 08	CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on September 19, 2023.	Nov. 14	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on September 19, 2023, has closed with 787,600 shares, representing 0.17% for CNY 49.99 million.	Nov. 13	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on September 19, 2023.	23-10-09	CI
China's Small Hospitals, Clinics Banking on AI to Bridge Barriers in Diagnosis, Treatment	23-09-19	MT
Kingmed Diagnostics to Repurchase Up to 50 Million Yuan Shares	23-09-19	MT
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	23-09-18	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan.	23-09-17	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Guangzhou Xinhongrui Investment Consulting Partnership (Limited Partnership), Guangzhou Xinhongyu Investment Consulting Partnership (Limited Partnership), Guangzhou Xinhongyu Investment Consulting Partnership (Limited Partnership) and Xie Jiangtao agreed to acquire 72% stake in Guangzhou Jinli Pharmaceutical Technology Co., Ltd. from Guangzhou Kingmed Diagnostics Group Co., Ltd. for CNY 220 million.	23-08-11	CI
GeneMind Biosciences Company Limited announced that it has received CNY 400 million in funding from Guangzhou Kingmed Diagnostics Group Co., Ltd., Shanghai Guoxin Investment Development Co. Ltd., Shenzhen High-Tech Investment Group Co., Ltd., Changzhou Shuangye Venture Capital, Hunan Caixin Capital Management Co., Ltd., Guochuang Zhiyuan Private Equity Fund	23-08-01	CI
GeneMind Biosciences Company Limited announced that it has received CNY 400 million in funding from Guangzhou Kingmed Diagnostics Group Co., Ltd., Shanghai Guoxin Investment Development Co. Ltd., Shenzhen High-Tech Investment Group Co., Ltd., Changzhou Shuangye Venture Capital, Hunan Caixin Capital Management Co., Ltd. and other investor	23-08-01	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24	CI

Chart Guangzhou Kingmed Diagnostics Group Co., Ltd.

Duration

Period

Chart Guangzhou Kingmed Diagnostics Group Co., Ltd.

More charts

Company Profile

Guangzhou Kingmed Diagnostics Group Co Ltd is a company that mainly provides medical diagnosis services. The Company is also engaged in other businesses, including sales of diagnostic products, provision of physical examination and cold chain logistics services.

Sector

Healthcare Facilities & Services

Calendar

2024-04-25 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Guangzhou Kingmed Diagnostics Group Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

42.55 CNY

Average target price

77.09 CNY

Spread / Average Target

+81.18%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-32.00%	2.75B
SONIC HEALTHCARE LIMITED	-16.65%	8.34B
RADNET, INC.	+39.98%	3.59B
SYNLAB AG	-7.71%	2.48B
DR. LAL PATHLABS LIMITED	-9.61%	2.32B
NEOGENOMICS, INC.	-13.29%	1.79B
FLEURY S.A.	-19.46%	1.54B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.57%	1.21B
METROPOLIS HEALTHCARE LIMITED	+9.70%	1.13B
ADICON HOLDINGS LIMITED	-14.57%	992M

Medical & Diagnostic Laboratories